Mimesis Law Podcast

Merck and Gilead Fight Could Become More Common | Markman Minute

Informações:

Sinopse

March 3, 2016 (Mimesis Law) - Merek and Gilliad are going to court over their hugely important Hepatitis-C treatment. Two pharmaceutical giants suing each over patents has been unusuall up until now, but Gaston Kroube of Markman Advisors thinks this is the beginning of a trend. Read more at MimesisLaw.com Mimesis’ Markman Minute | Intellectual Property & Patent LitigationIntellectual property attorney, consultant and blogger Gaston Kroub takes a deeper look at some of the biggest current patent stories of interest to investors. Subscribe to his daily posts at MimesisLaw.com. You can follow him on Twitter: @MarkmanAdvisors Mimesis Law covers the business, practice and culture of law. Mimesis Labs partners with companies and organizations to design, create and leverage video content. Lee Pacchia is the Founder and CEO.